Gadaleanu V - Search Results

1

Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancer.

Bjartell A, Paju A, Zhang WM, Gadaleanu V, Hansson J, Landberg G, Stenman UH. Bjartell A, et al. Among authors: gadaleanu v. Prostate. 2005 Jun 15;64(1):29-39. doi: 10.1002/pros.20236. Prostate. 2005. PMID: 15651064

2

Expression of somatostatin receptor subtypes 2 and 4 in human benign prostatic hyperplasia and prostatic cancer.

Hansson J, Bjartell A, Gadaleanu V, Dizeyi N, Abrahamsson PA. Hansson J, et al. Among authors: gadaleanu v. Prostate. 2002 Sep 15;53(1):50-9. doi: 10.1002/pros.10121. Prostate. 2002. PMID: 12210479

3

Localization and mRNA expression of somatostatin receptor subtypes in human prostatic tissue and prostate cancer cell lines.

Dizeyi N, Konrad L, Bjartell A, Wu H, Gadaleanu V, Hansson J, Helboe L, Abrahamsson PA. Dizeyi N, et al. Among authors: gadaleanu v. Urol Oncol. 2002 May-Jun;7(3):91-8. doi: 10.1016/s1078-1439(01)00173-9. Urol Oncol. 2002. PMID: 12474541

4

Expression of protein C inhibitor (PCI) in benign and malignant prostatic tissues.

Cao Y, Becker C, Lundwall A, Christensson A, Gadaleanu V, Lilja H, Bjartell A. Cao Y, et al. Among authors: gadaleanu v. Prostate. 2003 Nov 1;57(3):196-204. doi: 10.1002/pros.10296. Prostate. 2003. PMID: 14518028

5

Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland.

Bjartell A, Johansson R, Björk T, Gadaleanu V, Lundwall A, Lilja H, Kjeldsen L, Udby L. Bjartell A, et al. Among authors: gadaleanu v. Prostate. 2006 May 1;66(6):591-603. doi: 10.1002/pros.20342. Prostate. 2006. PMID: 16388501

6

Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines.

Dizeyi N, Bjartell A, Nilsson E, Hansson J, Gadaleanu V, Cross N, Abrahamsson PA. Dizeyi N, et al. Among authors: gadaleanu v. Prostate. 2004 May 15;59(3):328-36. doi: 10.1002/pros.10374. Prostate. 2004. PMID: 15042609

7

Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.

Cao Y, Lundwall A, Gadaleanu V, Lilja H, Bjartell A. Cao Y, et al. Among authors: gadaleanu v. Am J Pathol. 2002 Dec;161(6):2053-63. doi: 10.1016/S0002-9440(10)64484-7. Am J Pathol. 2002. PMID: 12466122 Free PMC article.

8

A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer.

Wegiel B, Bjartell A, Ekberg J, Gadaleanu V, Brunhoff C, Persson JL. Wegiel B, et al. Among authors: gadaleanu v. Oncogene. 2005 Sep 22;24(42):6385-93. doi: 10.1038/sj.onc.1208795. Oncogene. 2005. PMID: 16007189

9

Aberrant expression of cystatin C in prostate cancer is associated with neuroendocrine differentiation.

Jiborn T, Abrahamson M, Gadaleanu V, Lundwall A, Bjartell A. Jiborn T, et al. Among authors: gadaleanu v. BJU Int. 2006 Jul;98(1):189-96. doi: 10.1111/j.1464-410X.2006.06345.x. BJU Int. 2006. PMID: 16831167

10

Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.

Paju A, Hotakainen K, Cao Y, Laurila T, Gadaleanu V, Hemminki A, Stenman UH, Bjartell A. Paju A, et al. Among authors: gadaleanu v. Eur Urol. 2007 Dec;52(6):1670-9. doi: 10.1016/j.eururo.2007.01.096. Epub 2007 Feb 5. Eur Urol. 2007. PMID: 17306443

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters